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Intensive care unit-acquired weakness (ICUAW) is a common
condition in critically ill patients who are mechanically ventilated
for prolonged periods of time.1 [4_TD$DIFF] Only recently have mechanistic
studies shown that muscle atrophy and loss of muscle mass
develop rapidly during critical illness – within hours of the patient
being intubated and mechanically ventilated.2 Physiotherapists
play an integral role in the prevention and treatment of ICUAW
within the intensive care unit (ICU), with studies showing beneﬁt
from early mobilisation and inspiratory muscle training for
patients in the ICU to improve duration of weaning and functional
independence at hospital discharge.3,4 Most importantly, as
survival from ICU increases, physiotherapists will have a greater
role in the management of ICUAW after discharge from ICU and
hospital.
This review summarises the pathophysiology of ICUAW; the
diagnosis during critical illness; the respiratory and musculoskel-
etal consequences of ICUAW; the burden of ICUAW on survivors of
critical illness and their families; strategies to prevent andmanage
ICUAW, with a focus on speciﬁc physiotherapy interventions
during critical illness; and future directions for research and
practice.
What is intensive care unit-acquired weakness?
ICUAW is a clinical syndrome of generalised muscle weakness
that develops while a patient is critically ill, and for which there is
no alternate explanation other than the critical illness itself.1,5 [6_TD$DIFF]
ICUAW is caused by different pathologies, including critical illness
myopathy, polyneuropathy or a combination of both.6–8 It differs
from other neuromuscular disorders in the ICU in that facial and
ocular muscles are rarely involved, creatine kinase levels are not
elevated and demyelination is not a feature.1 In a recent binational,
multicentre cohort study, ICUAWwas present in more than 50% of
patients at ICU discharge who were mechanically ventilated for
greater than 48 hours.3http://dx.doi.org/10.1016/j.jphys.2016.10.011
1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).Diagnosis
Thediagnosis of ICUAWrequires a critical illness, or an illness of a
very high severity with prolonged organ support, that is usually
associatedwithaperiodofprotracted immobilisation.5,9 Key clinical
signs that support a diagnosis of ICUAW include the presence of
normal cognition, sparing of the cranial nerves, and the presence of
symmetrical ﬂaccid weakness. In an ofﬁcial American Thoracic
Society Clinical Practice Guideline, ICUAWwas reported to bemore
common in patients with severe sepsis, prolonged mechanical
ventilation, or difﬁculty with liberation from mechanical ventila-
tion.5 There was no consensus on the approach to diagnosis of
ICUAW, including how or when the diagnosis can be made.
Bedside examination of the ICU patient may be complicated by
the use of sedatives, neuromuscular blockers and delirium. In
clinical practice, physical examination of the muscle groups is
usually performed using the Medical Research Council (MRC)
Manual Muscle Test, which is dependent on patient effort and
cooperation.10,11 This scale evaluates muscle strength with a score
ranging from 0 (no muscle contraction) to 5 (full strength)
(Table 1). Physical examination of three muscle groups in each of
the upper and lower limbs results in a composite or sum score of
the MRC out of 60. Clinically detectable muscle weakness has been
deﬁned as 80% of the MRC sum score (ie, a score of < 48 out of a
total score of 60). This method has been proven reliable in a
cooperative patient.12,13 Other methods of volitional muscle
strength testing that are commonly used in the ICU include
handheld dynamometry.13,14 In a prospective, multicentre cohort
study, hand-held dynamometry was used to identify patients with
ICUAW and was independently associated with increased hospital
mortality.14
Pathophysiology
Muscle changes rapidly in the early days of critical illness.2,15–17
This acute phase response is demonstrated by a reduced ratio of
protein to DNA, depressedmuscle protein synthesis and a catabolic.V. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Medical Research Council (MRC) manual muscle testing for muscle strength.9
MRC Grade Clinical presentation is graded on patient effort
0 No movement is observed.
1 Only a ﬂicker or a trace of movement is seen or felt in the
muscle or fasciculations are seen in the muscle.
2 Muscle can move only if the resistance of gravity is
removed. As an example, the elbow can be fully ﬂexed only
if the arm is maintained in a horizontal plane.
3 Muscle strength is further reduced such that the joint can
be moved only against gravity with the examiner’s
resistance completely removed. As an example, the elbow
can be moved from full extension to full ﬂexion starting
with the arm hanging down at the side.
4 Muscle strength is reduced but muscle contraction can still
move joint against resistance.
5 Muscle contracts normally against full resistance.
Invited Topical Review 5state of proteolysis, which starts within the ﬁrst days of critical
illness andmay be accompanied by generalised weakness.2,18–20 In
addition, the interaction of bed rest and critical illness appears to
result in more signiﬁcant muscle loss than bed rest alone.17,21,22
There is evidence of loss of myosin and membrane excitability.
Overall, studies have shown that ICUAW results in decreased
muscle protein synthesis, increased muscle catabolism, and
decreasedmuscle mass with decreased force generation. However,
there may be signiﬁcant overlap in biological processes that
regulate both muscle mass and nerve contractility, and ICUAW
encompasses both critical illness polyneuropathy and myopathy;
it therefore may be accompanied by axonal nerve degenera-
tion.23,24 Additionally, there may be differences between the early
and late stages of skeletal muscle dysfunction that should be
considered in clinical practice.20
Risk factors for intensive care unit-acquired weakness
Bed rest
Both the pathophysiological mechanisms and risk factors are
multifactorial in the development of ICUAW in critically ill patients
(Box 1). As previously mentioned, in a large multicentre cohort
study of 222 patients with acute lung injury, duration of bed rest
was the only consistent factor that was associated with the
development of ICUAW.22 It is likely that a combination of both
disuse atrophy and inﬂammation with muscle catabolism results
in ICUAW; this challenges the current conventional model of care,
in which patients are sedated and immobilised for prolonged
periods during the ICU stay.
Sepsis and multi-organ failure
During critical illness, a catabolic statewithmusclewasting and
systemic inﬂammation occurs, particularly in patients with
sepsis.25 Two studies have reported a signiﬁcant association
between the presence and duration of systemic inﬂammatoryBox 1. Predictors of ICU-acquired weakness.
Intrinsic predictor variables Intensive care predictor
variables
 Age
 Medical comorbidities
 Frailty
 Level of independence
at admission
 Number of medical
comorbidities, including
mental health issues and
musculoskeletal pathology
 Hyperglycaemia
 Sepsis and inflammation
 Corticosteroids
 Prolonged use of
neuromuscular blockers
 Duration of ventilation
 Duration of bed rest
 Duration of ICU stay
[2_TD$DIFF] CU = intensive care unit.response syndrome and ICUAW in the ﬁrst week of ICU.26,27
Patients diagnosedwith sepsis have consistently been identiﬁed as
having long-term functional disability and should be assessed
early in the ICU stay for ICUAW.28,29 In a landmark publication of
patientswith acute respiratory distress syndrome (ARDS),multiple
organ failure was associated with long-term physical dysfunction
and poor health-related quality of life for up to 5 years.30
Hyperglycaemia
Hyperglycaemia is the most consistently identiﬁed risk factor
for ICUAW;31 [7_TD$DIFF] however, in a large multicentre Phase-III study of
intensive glucose control compared with standard care led by
investigators in Australia, tight glycaemic control was shown to
increase the odds ratio for death.32 Rather than managing patients
with tight glycaemic control, critically ill patients, particularly
those with hyperglycaemia, should be assessed for ICUAW and
managed with early intervention.
Corticosteroids
Following a prospective cohort study that demonstrated an
association between the use of corticosteroids and ICUAW,8 a
number of studies, including a systematic review, have failed to
support this association.31 Despite the current evidence, the use of
corticosteroids remains controversial in ICU, with concerns about
increased risk of ICUAW.
Neuromuscular blockers
Despite early concerns about the use of neuromuscular blockers
in the ICU, several prospective trials, a large, multicentre,
randomised, controlled trial and a recent systematic review have
failed to show an association between their use and ICUAW.33,34
Considering the mortality beneﬁt shown in patients with ARDS
with the early use (ﬁrst 48 hours) of neuromuscular blockers to
reduce lung injury, the use of these medications should be
considered on an individual basis. It is possible that prolonged use
of neuromuscular blockers in ICU patients has a different effect to
short-term use.
Burden of intensive care unit-acquired weakness
Duration of mechanical ventilation and length of ICU stay
Prolonged duration of mechanical ventilation and ICU stay is a
common manifestation of ICUAW. This can occur as a result of
weakness in both the diaphragm and the muscles of the chest wall
that requires prolonged mechanical support. In a systematic
review of ICU patients diagnosed with sepsis, 12 of 13 studies
demonstrated that ICUAW was associated with prolonged
mechanical ventilation.25
Survival and health-related quality of life
Severe weakness is common among survivors of critical illness,
and itmay persist for years.22,30 In a recent cohort study conducted
in 12 ICUs in Australia and New Zealand, over 50% of patients who
receivedmechanical ventilation for> 48 hours and survived to ICU
discharge were found to have ICUAW.3 The presence of ICUAW at
ICU discharge was associated with poor long-term outcome,
including increased 90-day mortality compared with patients who
did not have ICUAW.3 This has been conﬁrmed in international
cohort studies where increased weakness at discharge was
associated with increased risk of mortality at 12 months.35 ICUAW
has also been associated with poor health-related quality of life in
cohort studies in the years following critical illness.35–37 In one
cohort study of 13 ICUs in Baltimore, USA, duration of bed rest was
the only factor consistently associated with weakness after
discharge from hospital. At 2 years, patients with ICUAW had
reduced health-related quality of life and physical function
Hodgson and Tipping: Physiotherapy management of ICUAW6(measured with 6-minute walk test) compared with patients with
normal strength.22
It has been rare for studies of critically ill patients to
concurrently assess for both functional and pathophysiological
changes; therefore, these results should be interpreted cautious-
ly.38 There are still limitations in the understanding of mechanistic
changes inmuscle structure and function during critical illness and
their potential for effects on long-term outcomes, given the many
confounding factors that may affect patient recovery.39
Management of intensive care unit-acquired weakness
A summary of interventions used in themanagement of ICUAW,
along with the level of evidence that underpins their use, is
provided in Figure 1.
Inspiratory muscle training
Mechanical ventilation is a major factor in the disuse atrophy
and deconditioning of a patient’s respiratory muscles because it
may replace the spontaneous respiratory muscle effort. The
diaphragm in particular responds to invasive mechanical ventila-
tion with atrophy and proteolysis. Respiratory muscle weakness
may increase the duration of mechanical ventilation and prolong
the period of weaning from mechanical ventilation.40
Inspiratory muscle training has been used in an attempt to
improve diaphragmatic muscle strength in patients with ICUAW.
Evidence from a recent systematic review of 10 studies (including
394 participants) of inspiratory muscle training achieved by
threshold pressure training or ventilator sensitivity adjustment
showed that the training signiﬁcantly improved maximal
inspiratory pressure (MD 7 cmH2O, 95% CI 5 to 9), rapid shallow
breathing index (MD 15 breaths/minute/l, 95% CI 8 to 23) and
weaning success (RR 1.34, 95% CI 1.02 to 1.76).41 However,
difﬁculty in weaning is a key feature in ICUAW and in this
systematic review there was no difference in the reported
duration of weaning that was pooled from six of the studies
(MD1.7 days, 95%CI –0.3 to 3.6). The limitations of this systematic
review included differences between the studies in eligibility
criteria, training regimens and usual care (such as standardised
weaning and sedation protocols), which may have inﬂuenced the
results.41
In addition to this systematic review, there is a recently
published single-centre, randomised, controlled trial of inspiratory
muscle training in patients who had been successfully weaned
from mechanical ventilation for > 48 hours.42 In this study,
34 patients were randomly allocated to receive inspiratory muscle
training once daily for 5 days per week for 2 weeks as well as
standard care (intervention), and 36 patients were randomly
allocated to standard care only (control). The primary outcome
measures were inspiratory muscle strength and fatigue resistance
index at 2 weeks after enrolment. Similar to the previously
reported meta-analysis, the intervention group in this trial
demonstrated greater improvements in inspiratory muscle[(Figure_1)TD$FIG]
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Figure 1. Interventions for management of intensive care unit-acquired weakness, wit
ICU = intensive care unit, IMT = inspiratory muscle training, RCT = randomised controstrength (MD of the maximal inspiratory pressure, 11% predicted,
95% CI 2 to 20) but no difference in the fatigue resistance index (MD
0.02, 95% CI –0.15 to 0.12). Although inspiratory muscle strength
was improved, there was a concerning signal for higher in-hospital
mortality in the intervention group (4/34 versus 0/36, p = 0.051).
There were no between-group differences for measures of physical
function, dyspnoea, length of stay or ICU readmission. Survivors
reported improved health-related quality of life (measured with
the EuroQol ﬁve dimensions questionnaire, EQ-5D-3L) at 2 weeks
after enrolment compared with at the time of enrolment, with the
improvement being signiﬁcantly greater in the experimental group
(MD between groups 12%, 95% CI 1 to 23).42 [8_TD$DIFF]When this trial of IMT
after mechanical ventilation is combined with previous studies of
inspiratory muscle training during mechanical ventilation in a
meta-analysis, the body of evidence suggests that there is no
overall increased risk of mortality with inspiratorymuscle training
(Figure 2; for a detailed forest plot, see Figure 3 on the
eAddenda).98–101[9_TD$DIFF] Further studies are required to conﬁrm the
safety of inspiratory muscle training after patients are weaned
from mechanical ventilation.
In summary, current evidence for the effects of inspiratory
muscle training in patients during mechanical ventilation is
inconsistent, but does suggest a beneﬁt for improved inspiratory
muscle strength in ventilated patients. There is signiﬁcant
heterogeneity in the enrolment criteria, timing of intervention,
the training regimen, the control group and the outcomes
measured between the reported studies.41 Importantly, improved
muscle strength has not translated into evidence of improved
hospital outcomeswith regards to duration of weaning or length of
stay in ICU or hospital. In the recent randomised, controlled trial of
inspiratory muscle training after weaning from mechanical
ventilation,42 improvements reported in health-related quality
of life were measured within 2 weeks of the intervention,42 and
longer term outcomes need to be measured in a large trial.
Cycle ergometry
A cycle ergometer is a stationary bicycle that allows patients to
receive passive, active-assisted, and active-resistive exercise. In
the ICU, cycle ergometry may be used with sedated, immobile, or
awake patients to provide range of motion and muscle strength
training whilst patients are in bed.43,44 In a randomised trial
involving 90 mechanically ventilated patients with prolonged ICU
stays in Belgium, a 20-minute session of leg cycling on 5 days per
week in addition to standard care resulted in increased isometric
quadriceps force, higher self-perceived functional status, and
increased functional exercise capacity, as measured by the 6-
minute walk test at hospital discharge.45 There are several pilot
studies underway testing the use of cycle ergometry in the ICU,
which investigate its effect on muscle morphology,46 strength and
physical function.47 Further research is required to determine the
utility of cycle ergometry in the ICU to improve patient-centred
outcomes.abilitation commenced after 
more than 5 days in ICU
Early mobilisation in patients 
diagnosed with sepsis
 effect from the intervention Harm from the intervention
Post-ICU rehabilitation
h associated levels of evidence.
lled trial.
[(Figure_2)TD$FIG]
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Figure 2. Odds ratio (95% CI) of the effect of inspiratory muscle training on survival
in the intensive care unit. The odds of survival did not signiﬁcantly differ between
those who did and did not receive the training.
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In 2009, the National Institute for Health and Care Excellence
(NICE) published guidelines that recommended rehabilitation as a
key strategy in recovery for adult survivors of critical illness.48
These guidelines have been widely cited49–51 despite the lack of
evidence to support post-ICU rehabilitation (ward-based, outpa-
tient-based or home-based) to improve outcomes in this cohort.52–
54
A Cochrane review of exercise rehabilitation following ICU
discharge for recovery from critical illness assessed the effective-
ness of exercise programs on functional exercise capacity and
health-related quality of life.55 Six trials were included, providing
data on 483 adult ICU survivors. Interventions were delivered on
the wards or in the community, and the duration of the
interventions varied according to hospital length of stay, with a
maximum of 12 weeks of rehabilitation after ICU discharge. The
studies included a range of interventions, such as arm and leg
cycling exercises, walking, strengthening exercises, provision of
self-help manuals and programs that were based in physiotherapy
outpatient departments that included a combination of functional
and strengthening exercises and education. All of the studies
measured functional exercise capacity, but there was signiﬁcant
variability in the outcomemeasures and data reported, and overall
the quality of the evidence was low.55 The review was unable to
determine an overall result for the effects of an exercise-based
intervention, with three studies reporting an improvement in
functional exercise capacity and three studies reporting no effect.
Due to the different outcomemeasures used in the studies, the data
were unable to be meta-analysed. Importantly, the authors
reported a lack of acknowledgement of standard practice, which
might have affected the results. For example, the usual level of
rehabilitation and exercise in standard practice may have
inﬂuenced the results of the studies.55
Since the publication of that Cochrane review, a large,
randomised, controlled trial of post-ICU rehabilitation in the UK
has been published.54 Walsh and colleagues randomised
240 patients who had received at least 48 hours of mechanical
ventilation to receive a complex intervention led by a rehabilita-
tion coordinator that included additional physiotherapy, nutri-
tional review, individualised goal setting and illness-speciﬁc
information. There were no between-group differences for the
primary outcome measure at 3 months (Rivermead Mobility
Index) or for any other functional or quality of life outcomes at any
time point. The study found that patients in the intervention group
reported greater satisfaction with physiotherapy, nutritional
support, coordination of care, and information provision. Thisstudy highlights the importance of coordination of care after
critical illness in this cohort.
Preventing intensive care unit-acquired weakness
Electrical muscle stimulation
Electrical muscle stimulation (EMS) has been investigated as a
treatment for the prevention of ICUAW.56,57 It involves placing
transcutaneous electrodes over the skin, which activate the
underlying nerves to produce an isometricmuscle contraction.43,58
The treatment involves minimal joint movement and does not
require patient interaction.56,57
Three systematic reviews (including eight randomised trials)
have assessed the use of EMS in the critically ill population.59–61
The EMS treatments provided across the studies were 30 to
60 minutes in duration, daily, for at least 4 days. The exact
treatment protocols varied in the muscles that were stimulated,
the duration of therapy, and the pulse characteristics and impulse
intensity of the EMS.59–61 Meta-analysis was only completed in
one of the systematic reviews, with the pooled results of two
studies showing increased quadriceps femoris strength in the EMS
group compared with the control group, measured with the MRC
scale (MD 0.77, 95% CI 0.19 to 1.40, n = 80).59 In these studies,
patient acuity was measured with the Acute Physiology and
Chronic Health Evaluation II (APACHE II) score. Individually, one
study with lower patient acuity (median APACHE II scores of 16)
demonstrated greater preservation of muscle mass with EMS (8 to
14% reduction),62 whilst two studies with higher patient acuity
(median APACHE II scores of 20 and 25) demonstrated a greater
degree of muscle mass loss and that EMS did not preserve muscle
mass (16 to 20% reduction).63,64 One study demonstrated
signiﬁcantly greater quadriceps muscle thickness in the EMS
group (+4.9%) compared with the placebo (–3.2%) using EMS in
long-stay ICU patients,65 and one study demonstrated increased
rates of ICUAW in the placebo group (39%) compared with the EMS
group (13%).66 Routsi and colleagues also demonstrated a shorter
weaning period from mechanical ventilation in the EMS group
(median 1, range 0 to 10) compared with the control group
(median 3, range 0 to 44, p = 0.003), and a shorter period from
weaning from mechanical ventilation to ICU discharge in the EMS
group compared with the control group (median 4 days, range 0 to
16, versus 6 days, range 0 to 41, respectively, p = 0.003).66
There are several concerns reported in the systematic reviews
about the included studies. First, the studies visually determined
the muscle contraction, which may have been unreliable.60 There
was a lack of high-quality studies and some studies used higher
pulse durations and intensity than recommended by some
authors,67 [10_TD$DIFF] which may have caused fatigue and skewed the
results.59 There was a large amount of heterogeneity in the
treatment protocols and outcome measures used, which limited
meta-analysis. This suggests that researchers are not yet sure what
is important in terms of procedure and outcome measures for
EMS.59
The results of these studies indicate that EMS might be an
attractive intervention for critically ill patients and it may have the
ability to maintain muscle mass and strength in the ICU setting,59
particularly in long-stay ICU patients and those with lower levels
of acuity. Further large, randomised, controlled trials need to be
completed to determine the overall effect of EMS and the most
appropriate training regimen.60
Mobilisation in the ICU
Mobilisation of mechanically ventilated patients in the ICU has
been shown to be feasible and safe.4,68,69 Numerous randomised
trials have investigated the use of early mobilisation in the ICU,
with the intervention starting within 3 days of ICU admission70–73
or starting later in the ICU admission (after 5 days).74,75 It is
[(Figure_4)TD$FIG]
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Figure 4. Odds ratio (95% CI) of ICUAW with or without mobilisation and
rehabilitation in the ICU. Overall, mobilisation and rehabilitation reduced the odds
of ICUAW. When studies were subgrouped into mobilisation and rehabilitation
started within 3 days of admission to ICU (early) or after more than 5 days in ICU
(late), the odds of ICUAW were only signiﬁcantly reduced with early mobilisation
and rehabilitation compared with standard care. ICU = intensive care unit, ICUAW =
Intensive Care Unit Acquired Weakness.
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regards to time from ICU admission to the start of early
mobilisation, and time from randomisation to the start of
rehabilitation, which might be different if there is a long period
between ICU admission and randomisation into the study.
The results of the individual studies are conﬂicting, with some
studies reporting no beneﬁt,74–76 whilst others report improved
function at hospital discharge,73,77 greater independent walking
distance,73,78 higher mobility milestones,71,77 decreased duration
of mechanical ventilation,73,79 increased muscle strength80 and
improved quality of life of survivors72 favouring the intervention
group. One study reported signiﬁcantly lower 6-minute walk test
results in the early rehabilitation group compared with the control
at ICU discharge (MD 42 m, 95% CI 4 to 79).74 Whilst previous
systematic reviews81,82 have assessed the impact of mobilisation
in the ICU, they have had limited ability to complete meta-analysis
due to the heterogeneity in the study designs, in particular the
outcome measures used and the timing of these assessments. To
date, the signiﬁcant results supportingmobilisation in the ICUwith
improvements in function, mobility and quality of life have been
reported in studies that commenced the intervention early in the
ICU stay.71–73,77 This may demonstrate a greater ability for early
mobilisation to prevent ICUAW and long-term functional impair-
ments than to treat muscle weakness once it is established.83
A recent systematic review and meta-analysis of early
rehabilitation during ICU stay on functional status demonstrated
a greater probability of walking without assistance at hospital
discharge in the early mobilisation group compared with the
control group (pooled RR 1.42, 95% CI 1.17 to 1.71, four studies).81
This systematic review and meta-analysis also reported the risk
ratio for ICUAW between the intervention and control groups
(pooled RR 0.75, 95% CI 0.51 to 1.09, three studies). However, this
analysis pooled studies that included both electrical muscle
stimulation and early mobilisation, and measured ICUAW at
different points in the patient’s trajectory. An updated pooled
analysis of the proportion of patients who developed ICUAW in
studies of early mobilisation demonstrates a lower risk of ICUAW
in the early mobilisation group compared with the control group
(OR 0.54, 95% CI 0.32 to 0.91) (Figure 4; for a detailed forest plot,
see Figure 5 on the eAddenda).71,73,74 The sensitivity analysis
demonstrates that the results are driven by the two studies that
commenced mobilisation within 3 days of ICU admission.71,73
We need to carefully consider strategies for retention of
patients into studies that measure long-term outcomes after
critical illness, including registry linkages.84,85 To this end, there
are excellent resources available from experts in the ﬁeld that
should be considered for use in ICU studies requiring follow-up.86
Several recent studies of mobilisation and rehabilitation that
measured long-term recovery after hospital discharge have
demonstrated that a large number of participants were lost to
follow-up or withdrew from the trial.54,74,75,77 Finally, there is an
urgent need for a large trial to conﬁrm the impact of mobilisation
in the ICU on patient-centred, long-term outcomes.83,84 In some
other areas of clinical practice, earlymobilisation of acutely unwell
patients has not demonstrated improved patient-centred out-
comes,87,88 and this may be true in speciﬁc ICU cohorts, for
example patients with severe sepsis.72
Future directions for research and practice
There are several important considerations for the physiother-
apy management of patients in the ICU who are at risk of
developing ICUAW or who have been diagnosed with ICUAW. One
of the criticisms of previous randomised trials assessing strength
and function of patients in the ICU is the heterogeneous
population. There is no measurement of baseline function that
may affect the ability to recover, with evidence that patients who
are older andwith comorbid conditions are less likely to respond to
interventions.89–91Similarly, the risks and beneﬁts for speciﬁc diagnostic groups
are currently unknown. One study demonstrated increased
mortality in septic patients who received early mobilisation72
(and direct communication with authors). Another study demon-
strated increased mortality with inspiratory muscle training
commenced after weaning from mechanical ventilation.42 The
study by Schweickert et al. that demonstrated improved recovery
at hospital discharge included a heterogeneous population, but the
participants were all functionally independent prior to ICU
admission.73 Another study in the surgical population demon-
strated decreased length of hospital stay, with patients also
functionally independent prior to ICU admission.77 Therefore,
there is an urgent need for future studies to identify responders
and non-responders to mobilisation and rehabilitation in the
ICU.90,92
Increasingly, physiotherapists have focused on exercise-based
interventions in the ICU, including both bed exercises and
mobilisation out of bed.81,82 These have been shown to be safe
and effective during the ICU stay4,68,93 and there is evidence that
they may reduce hospital length of stay and improve functional
independence at hospital discharge.73 This appears to be more
apparent in studies that randomised patients early (within 3 days)
of the ICU stay.71–73 However, there is an urgent need for research
that helps us to understand the risks versus the beneﬁts of early
mobilisation and rehabilitation on long-term outcomes and
patient recovery beyond the hospital stay.84,85 Until the long-
term outcomes are assessed in an adequately powered, multi-
centre trial, the safety of the intervention remains unclear.
In the past 12 months, several new randomised, controlled
trials have assessed the effect of physiotherapy and early
rehabilitation in patients with acute respiratory failure.75–77
Whilst the number of studies in this ﬁeld is increasing, there is
no clear evidence of a dose-response in critically ill patients. Few of
these studies have published precise data on the dosage of exercise
per patient. Future studies could improve the understanding of the
dose-response by providing this valuable information. This would
require information about the timing and duration of exercise
(minutes) and the type of exercise delivered, using a valid
Invited Topical Review 9measurement tool. There is an active international research
agenda to develop a core set of outcome measures for patients
after ICU.94–96 This is urgently required because the larger trials
that have measured long-term outcome have included different
outcome measures of strength, physical function and health-
related quality of life, therefore limiting the ability to pool the
results.97 In the future, ICU research assessing strength and
function should include a core set of outcome measures to allow
comparison between studies.94
In the clinical setting, physiotherapists have a growing body of
evidence to guide practice when treating patients during critical
illness (Figure 1). ICUAW is common and occurs rapidly during the
ICU stay; however, the evidence for important beneﬁts of early
physiotherapy interventions in ICU is not strong.9 It is possible that
early interventions, including inspiratory muscle training, early
mobilisation and cycle ergometry, reduce ICUAW and improve
independence at hospital discharge; however, currently it is
unclear which intervention, timing and dosage is best to prevent or
treat ICUAW.83 There are several ongoing studies that will inform
long-term outcomes for patients in this area of practice in the
future.
eAddenda: Figures 3 and [11_TD$DIFF]5 can be found online at doi:10.1016/j.
jphys.2016.10.011
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